157 related articles for article (PubMed ID: 19941475)
21. Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer.
Chanakira A; Westmark PR; Ong IM; Sheehan JP
Gynecol Oncol; 2017 Apr; 145(1):167-175. PubMed ID: 28148395
[TBL] [Abstract][Full Text] [Related]
22. Commutators of PAR-1 signaling in cancer cell invasion reveal an essential role of the Rho-Rho kinase axis and tumor microenvironment.
Nguyen QD; De Wever O; Bruyneel E; Hendrix A; Xie WZ; Lombet A; Leibl M; Mareel M; Gieseler F; Bracke M; Gespach C
Oncogene; 2005 Dec; 24(56):8240-51. PubMed ID: 16091733
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
Wu CC; Teng CM
Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
[TBL] [Abstract][Full Text] [Related]
24. Potent non-peptide thrombin receptor antagonists.
Chackalamannil S; Ahn HS; Xia Y; Doller D; Foster C
Curr Med Chem Cardiovasc Hematol Agents; 2003 Mar; 1(1):37-45. PubMed ID: 15317289
[TBL] [Abstract][Full Text] [Related]
25. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
[TBL] [Abstract][Full Text] [Related]
26. Pravastatin and C reactive protein modulate protease- activated receptor-1 expression in vitro blood platelets.
Chu LX; Zhou SX; Yang F; Qin YQ; Liang ZS; Mo CG; Wang XD; Xie J; He LP
Cell Mol Biol (Noisy-le-grand); 2016 Feb; 62(2):75-80. PubMed ID: 26950455
[TBL] [Abstract][Full Text] [Related]
27. Discovery of novel protease activated receptors 1 antagonists with potent antithrombotic activity in vivo.
Perez M; Lamothe M; Maraval C; Mirabel E; Loubat C; Planty B; Horn C; Michaux J; Marrot S; Letienne R; Pignier C; Bocquet A; Nadal-Wollbold F; Cussac D; de Vries L; Le Grand B
J Med Chem; 2009 Oct; 52(19):5826-36. PubMed ID: 19791800
[TBL] [Abstract][Full Text] [Related]
28. Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions.
Hosokawa K; Ohnishi T; Miura N; Sameshima H; Koide T; Tanaka KA; Maruyama I
Thromb Res; 2014 Jan; 133(1):66-72. PubMed ID: 24268424
[TBL] [Abstract][Full Text] [Related]
29. Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes.
Sorensen SD; Nicole O; Peavy RD; Montoya LM; Lee CJ; Murphy TJ; Traynelis SF; Hepler JR
Mol Pharmacol; 2003 Nov; 64(5):1199-209. PubMed ID: 14573770
[TBL] [Abstract][Full Text] [Related]
30. Stimulation of naïve monocytes and PBMCs with coagulation proteases results in thrombin-mediated and PAR-1-dependent cytokine release and cell proliferation in PBMCs only.
Nieuwenhuizen L; Falkenburg WJ; Schutgens RE; Roosendaal G; van Veghel K; Biesma DH; Lafeber FP
Scand J Immunol; 2013 May; 77(5):339-49. PubMed ID: 23421536
[TBL] [Abstract][Full Text] [Related]
31. The Complex Role of Thrombin in Cancer and Metastasis: Focus on Interactions with the Immune System.
Aleksandrowicz K; Hempel D; Polityńska B; Wojtukiewicz AM; Honn KV; Tang DG; Wojtukiewicz MZ
Semin Thromb Hemost; 2024 Apr; 50(3):462-473. PubMed ID: 37984359
[TBL] [Abstract][Full Text] [Related]
32. Role for Thrombin Receptor Antagonism With Vorapaxar in Secondary Prevention of Atherothrombotic Events: From Bench to Bedside.
Moon JY; Franchi F; Rollini F; Angiolillo DJ
J Cardiovasc Pharmacol Ther; 2018 Jan; 23(1):23-37. PubMed ID: 28565918
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of novel peptide inhibitors of thrombin-induced platelet activation.
Burke FM; Warnock M; Schmaier AH; Mosberg HI
Chem Biol Drug Des; 2006 Nov; 68(5):235-8. PubMed ID: 17177882
[TBL] [Abstract][Full Text] [Related]
34. Protease-activated receptors (PAR)-1 and -3 drive epithelial-mesenchymal transition of alveolar epithelial cells - potential role in lung fibrosis.
Wygrecka M; Didiasova M; Berscheid S; Piskulak K; Taborski B; Zakrzewicz D; Kwapiszewska G; Preissner KT; Markart P
Thromb Haemost; 2013 Aug; 110(2):295-307. PubMed ID: 23739922
[TBL] [Abstract][Full Text] [Related]
35. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
[TBL] [Abstract][Full Text] [Related]
36. Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis.
Rullier A; Gillibert-Duplantier J; Costet P; Cubel G; Haurie V; Petibois C; Taras D; Dugot-Senant N; Deleris G; Bioulac-Sage P; Rosenbaum J
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G226-35. PubMed ID: 17962354
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of platelet activation by thrombin: a short history.
De Candia E
Thromb Res; 2012 Mar; 129(3):250-6. PubMed ID: 22137742
[TBL] [Abstract][Full Text] [Related]
38. Synergistic effect of thrombin on collagen-induced platelet procoagulant activity is mediated through protease-activated receptor-1.
Keuren JF; Wielders SJ; Ulrichts H; Hackeng T; Heemskerk JW; Deckmyn H; Bevers EM; Lindhout T
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1499-505. PubMed ID: 15845904
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of Arylpiperazine Derivatives as Protease Activated Receptor 1 Antagonists and Their Evaluation as Antiproliferative Agents.
Zotti AI; Di Gennaro E; Corvino A; Frecentese F; Magli E; Perissutti E; Cirino G; Roviezzo F; Terranova-Barberio M; Iannelli F; Caliendo G; Santagada V; Fiorino F; Budillon A; Severino B
Anticancer Agents Med Chem; 2017; 17(7):973-981. PubMed ID: 27671294
[TBL] [Abstract][Full Text] [Related]
40. Protease-Activated Receptor-1 Antagonists Post-Percutaneous Coronary Intervention.
Tricoci P
Interv Cardiol Clin; 2017 Jan; 6(1):57-66. PubMed ID: 27886823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]